Invenomic Capital Management’s Centene CNC Stock Holding History

Invenomic Capital Management’s Portfolio CNC Stock Details CNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-352,421	Closed	-$24.3M	–	180
2023 Q3	$24.3M	Sell	352,421 -255,079	-42%	-$17M	1.02%	27
2023 Q2	$41M	Sell	607,500 -24,024	-4%	-$1.6M	2.08%	10
2023 Q1	$39.9M	Buy	631,524 +474,372	+302%	+$33.7M	2.25%	8
2022 Q4	$12.9M	Buy	+157,152	New	+$12.8M	0.87%	37
2021 Q4	–	Sell	-66,802	Closed	-$4.16M	–	147
2021 Q3	$4.16M	Buy	66,802 +9,469	+17%	+$633K	1.35%	25
2021 Q2	$4.18M	Sell	57,333 -1,739	-3%	-$119K	1%	19
2021 Q1	$3.78M	Buy	+59,072	New	+$3.66M	0.84%	21

Other funds holding CNC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

PCM

Politan Capital Management New York $985M AUM 3.12% 1-Year Est. Return

Invenomic Capital Management's CNC Position: Q4 2023 in Review

Invenomic Capital Management sold out of Centene (CNC) in Q4 2023, closing a stake of 352,421 shares — an estimated $24.3M sold.

Invenomic Capital Management first reported a position in CNC in Q1 2021 and held it in 7 quarters. The position peaked at $41M in Q2 2023. 893 funds tracked by Wall St. Rank hold CNC as of Q4 2023.

Invenomic Capital Management reported no remaining Centene position as of Q4 2023 after selling out during the quarter.
Invenomic Capital Management sold 352,421 Centene shares in Q4 2023, an estimated $24.3M.
Invenomic Capital Management first reported a position in Centene in Q1 2021 and held it in 7 quarters.
Invenomic Capital Management's Centene position peaked at $41M in Q2 2023.
893 funds tracked by Wall St. Rank held Centene as of Q4 2023.

Based on Invenomic Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.